Oct 22 2010
SANITIZED AG, launches Sanitized® MedX 200s, the new silver product series for medical devices. SANITIZED AG expects to receive confirmation for its effectiveness against antibiotic-resistant bacteria NDM-1 shortly.
Sanitized® Silver products have been highly prized for their high quality standards by international plastic manufactures for years. For the first time, SANITIZED AG has now moved its comprehensive silver expertise to the medical field. The result is a new Sanitized® MedX 200s active agent series, which can be used for polyolefin, thermoplastic elastomers, PVCs, and engineering polymers. When embedded in polymers, Sanitized® MedX 200s allows reduction of bacteria populations on the surface of treated medical devices – permanently and reliably.
Effective against MRSA and VRE
The new Sanitized® product series covers a broad antimicrobial spectrum, including gram-positive and gram-negative bacteria. Sanitized® MedX 200s is effective against MRSA and VRE. Confirmation of its effectiveness against NDM-1, a carbapenem antibiotic-resistant bacteria, by a neutral testing agency will be available shortly. Corresponding trials are already underway. Sanitized® MedX 200s is an active contribution to reducing the danger of Healthcare-Associated Infections, HAI.
SANITIZED AG works together with Clariant BU Masterbatches in this area. The new Sanitized® MedX 200 series is being used in developments in Clariant’s MEVOPUR® masterbatches and compounds for medical and pharmaceutical applications, launched at K2010.
Dr. Bruno Piastra, product manager in charge at SANITIZED AG, is convinced of the success of the new active ingredient series: “Our many years of experience with the antimicrobial effectiveness of silver based technology flowed into the development of Sanitized® MedX 200s by following our natural imperative for highest quality standards. Manufacturers of medical devices benefit from our competence and can place their trust in a safe and reliable product.”